Skip to main navigation Skip to search Skip to main content

SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: 5-YEAR DATA FROM TENDER, A PHASE 3 CLINICAL TRIAL

  • F. De Benedetti
  • , N. Ruperto
  • , H. Brunner
  • , C. Keane
  • , C. Wells
  • , J. Wang
  • , I. Calvo
  • , R. Cuttica
  • , A. Ravelli
  • , R. Schneider
  • , D. Eleftheriou
  • , C. Wouters
  • , R. Xavier
  • , L. Zemel
  • , E. Baildam
  • , R. Burgos-Vargas
  • , P. Dolezalova
  • , S. M. Garay
  • , R. Joos
  • , A. Grom
  • N. Wulffraat, Z. Zuber, F. Zulian, A. Martini, D. Lovell

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)384-384
JournalAnnals of the Rheumatic Diseases
Volume74
DOIs
Publication statusPublished - Jun 2015

Cite this